BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4735112)

  • 1. A common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue.
    Dickinson JP; Caspary EA; Field EJ
    Br J Cancer; 1973 Feb; 27(2):99-105. PubMed ID: 4735112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid development of a cancer-like antigen in normal tissue in vitro.
    Field EJ; Hughes D; Caspary EA
    Br J Cancer; 1973 Jun; 27(6):427-33. PubMed ID: 4737227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte sensitization to basic protein of brain in malignant neoplasia: experiments with serotonin and related compounds.
    Field EJ; Caspary EA; Carnegie PR
    Nature; 1971 Sep; 233(5317):284-6. PubMed ID: 4106472
    [No Abstract]   [Full Text] [Related]  

  • 4. The macrophage electrophoretic mobility test for malignancy.
    Lubran MM
    Ann Clin Lab Sci; 1974; 4(2):121-4. PubMed ID: 4132114
    [No Abstract]   [Full Text] [Related]  

  • 5. Differences of the in vitro reactivity of lymphocytes from normal and persistently lymphocytotic cows to enzootic bovine leukosis tumour membrane extracts as detected with the macrophage-electrophoretic mobility test.
    Ristau E; Schlott B; Gryschek G; Wittmann W
    Acta Biol Med Ger; 1982; 41(7-8):705-13. PubMed ID: 7148278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modulation of tumour-versus-host response in lung, colon, and breast cancer patients: implications for adjuvant immunochemotherapy.
    Steward AM
    Aust N Z J Surg; 1977 Oct; 47(5):642-7. PubMed ID: 273408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
    Field EJ; Caspary EA; Smith KS
    Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization to tumour-associated antigens in human breast carcinoma.
    Cochran AJ; Grant RM; Spilg WG; Mackie RM; Ross CE; Hoyle DE; Russell JM
    Int J Cancer; 1974 Jul; 14(1):19-25. PubMed ID: 4617707
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologic localization of primary tumors].
    Muhrer KH; Filler D; Pasurka B
    Chirurg; 1982 Apr; 53(4):258-62. PubMed ID: 7083967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Br J Cancer Suppl; 1973 Aug; 1():229-36. PubMed ID: 4804283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage migration inhibition test: experimental and clinical studies.
    Akiyama T; Yamaura N; Kenjo T; Omura T; Matsuda R
    Keio J Med; 1971 May; 20(1):15-27. PubMed ID: 4336949
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte sensitization and ageing.
    Field EJ; Smith JK
    Gerontologia; 1972; 18(4):185-92. PubMed ID: 4122172
    [No Abstract]   [Full Text] [Related]  

  • 13. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological cross-reactivity between acid extracts of myelin, liver and neoplastic tissues: studies in immunized guinea-pigs.
    Flavell DJ; Goepel J; Wilson AP; Potter CW
    Br J Cancer; 1979 Sep; 40(3):424-36. PubMed ID: 92328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between the macrophage migration inhibition test (MMI) and the leucocyte adherence inhibition test (LAI) in patients with melanoma and carcinoma of the colon.
    Isbister WH
    N Z Med J; 1978 Oct; 88(622):327-30. PubMed ID: 366475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of an "antigen" from malignant tumours.
    Carnegie PR; Caspary EA; Field EJ
    Br J Cancer Suppl; 1973 Aug; 1():219-23. PubMed ID: 4804281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenicity of a fetal extract in the leucocyte migration-inhibition test.
    Uehara Y; Kojima O; Kitagawa N; Oh A; Nishioka B; Fujita Y; Majima S
    Oncodev Biol Med; 1983; 4(5):335-41. PubMed ID: 6856483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common tumour-specific antigen: III. Preparation of small fragments incorporating the cell-sensitizing determinant.
    Dickinson JP; McDermott JR; Smith JK; Caspary EA
    Br J Cancer; 1980 Aug; 42(2):266-74. PubMed ID: 6158971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte sensitization in malignant neoplasia.
    Caspary EA
    Proc R Soc Med; 1972 Jul; 65(7):636-8. PubMed ID: 5085945
    [No Abstract]   [Full Text] [Related]  

  • 20. The macrophage electrophoretic migration test in cancer.
    Goldstone AH; Kerr L; Irvine WJ
    Clin Exp Immunol; 1973 Jul; 14(3):469-72. PubMed ID: 4125154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.